The board of directors, composed of seven members, is the Company´s decision-making body responsible for formulating general directives and business guidelines, including offering guidance on its long-term strategies.

The members are appointed for a period of two years and may be reelected. Decisions of the board of directors are adopted by a majority vote of the directors present or represented at such meeting.

Director
  • 35+ years of experience working in the health, wellness and consumer goods sectors
  • Co-founder of WM Partners, a middle-market private equity firm focused on the health and wellness industry
  • Board member of Grupo Procaps, Gelco Gelatin and Descafecol B.S. in Management Engineering from Worcester Polytechnic Institute and a Certificate in Mergers and Acquisitions from the Kellogg School of Management
Independent Director
  • 15 years of experience in public markets investing and SPAC management, and direct equity and debt private markets principal investing, capital raising, and investment banking
  • Founder and Chief Executive Officer of Union Acquisition Group and Independent Director NASDAQ: BIOX and NASDAQ: PROC.
  • Served as Chief Executive Officer Director at Union Acquisition Corp II (Nasdaq: LATIN)
  • Currently serves as an Independent Director of Bioceres Crop Solutions (NYSE: BIOX) and Procaps Group (NASDAQ: PROC) and was formerly CEO and Director of Union Acquisition Corp. (NYSE: LTN) and CEO and Director of Union Acquisition Corp. II (Nasdaq:LATN).
  • Finance, Economics from American University - Kogod School of Business
Independent Director
Independent Director
  • 20+years of experience in global healthcare and pharma companies with a successful track record in value-creating transactions, international business, strategic planning, and mergers and acquisitions of public and private companies
  • Previously, served as Board Member of several private and listed companies, including CFR Pharmaceuticals S.A., Clínica Las Condes S.A. and Chairman of the Board of Laboratorio Chile S.A
  • Master’s in Commercial Law from Duke University School of Law

Investor Contact Information

Company

Procaps Group
9 Rue De Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Procaps Group Company Contact
Melissa Angelini
Investor Relations Director
ir@procapsgroup.com
mangelini@procapsgroup.com

Search Investor Relations